SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spine-Tech (SPYN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jbershad who wrote (167)8/14/1997 11:28:00 AM
From: .com   of 242
 
Spine-tech Inc (SPYN)

SPINE-TECH INC. shares continued to fall Wednesday, losing 5.8%, because of concerns among
investors that a potential competitor in spinal-fusion cages could be on the market earlier than previously
thought. The company's shares have fallen nearly 20% since hitting a 52-week high of 61 1/4 on July
30. (Dow Jones)

Spine-tech Inc (SPYN)

Hambrecht and Quist analyst Robert Faulkner downgraded SPINE-TECH INC to a hold from a strong
buy, because of doubts the company will receive early approval for its Sofamor Danek's cage for use in
spinal fusion procedures. "We continue to have no concerns about Spine-Tech fundamentals in the
near-term," Faulkner said in a research report. "The company is doing an excellent job of expanding its
sales force and training surgeons and demand appears to grow unabated in the market." "The key new
point is ongoing uncertainty, with no near-term resolution in sight, on the issue of early approval in
1998 for Sofamor Danek's cage, rather than early 1999. We continue to doubt that Sofamor Danek
receives early approval. (Reuters 04:34 PM ET 08/13/97)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext